Startups

Frederick’s Veralox Therapeutics raises $5.4M seed round

The round was led by the JDRF T1D Fund and Sanofi Ventures, and included a pair of local investors.

Frederick, Maryland. (Photo by Flickr user Ron Cogswell, used under a Creative Commons license)

Frederick-based Veralox Therapeutics said it raised $5.4 million in seed funding as it works to develop therapeutics to treat underlying causes of thrombosis and type 1 diabetes.

Founded in 2017, the company was founded by Drs. Jeffrey Strovel, David Maloney and Matthew Boxer. The company’s lead candidate therapeutic, called VLX-1005, was developed with the University of California Santa Cruz, Thomas Jefferson University, NIH and Eastern Virginia Medical School. The company’s therapeutics are designed to block a specific enzyme that is involved in the rare condition heparin-induced thrombocytopenia and thrombosis, as well as type 1 diabetes.

The new funding will be used for pre-clinical development activities, which is the research that takes place before testing in humans.

The round was co-led by Boston-based JDRF T1D Fund, which is specifically focused on backing efforts to address Type 1 diabetes, and Sanofi Ventures. VTC Innovation, VTC Seed Fund and the University of Vermont Health Network also participated. From Maryland, state-backed TEDCO and the University System of Maryland’s Maryland Momentum Fund contributed to the round.

With the investment, Sanofi Ventures’ Daniel Mansuri and JDRF T1D Fund Managing Director Katie Ellias are joining the company’s board.

“With the support of the T1D Fund, Sanofi Ventures, and our other investors, we are well positioned to broaden the potential indications for our technology while ensuring sufficient capital to prepare for clinical studies in patients,” Strovel, the company’s CEO, said in a statement.

The company becomes the latest sign of interest in Frederick’s biotech activities. RoosterBio raised $15 million in Series B funding last month, while earlier this year Kite Pharma announced plans for a new manufacturing facility in Frederick County.

Before you go...

Please consider supporting Technical.ly to keep our independent journalism strong. Unlike most business-focused media outlets, we don’t have a paywall. Instead, we count on your personal and organizational support.

3 ways to support our work:
  • Contribute to the Journalism Fund. Charitable giving ensures our information remains free and accessible for residents to discover workforce programs and entrepreneurship pathways. This includes philanthropic grants and individual tax-deductible donations from readers like you.
  • Use our Preferred Partners. Our directory of vetted providers offers high-quality recommendations for services our readers need, and each referral supports our journalism.
  • Use our services. If you need entrepreneurs and tech leaders to buy your services, are seeking technologists to hire or want more professionals to know about your ecosystem, Technical.ly has the biggest and most engaged audience in the mid-Atlantic. We help companies tell their stories and answer big questions to meet and serve our community.
The journalism fund Preferred partners Our services
Engagement

Join our growing Slack community

Join 5,000 tech professionals and entrepreneurs in our community Slack today!

Trending

Let’s vote (again), Baltimore: Meet your 2024 Technical.ly Award nominees

High school seniors in Maryland are getting daily AI training 

Cannabis gets the spotlight at a DMV tech conference

What a second Trump administration means for local startup ecosystems

Technically Media